SCHEMBL18974296

SCHEMBL18974296

N#Cc1ccccc1CN1C(=O)C(=O)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 2/20 0.57
CES1 P23141 7/20 0.56
ALDH1A1 P00352 4/20 0.56
ALDH3A1 P30838 3/20 0.56
CHRM1 P11229 2/20 0.56
ALDH2 P05091 2/20 0.56
BCHE P06276 4/20 0.54
ACHE P22303 2/20 0.54
CES2 O00748 1/20 0.52
CHRM5 P08912 2/20 0.51
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
CHRM3 P20309 1/20 0.51
APAF1 O14727 1/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 1/20 0.48
ALOX15 P16050 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658723 0.84 ACHE (0.62) TGM2ALDH1A1ACHECHRM5TP53
SCHEMBL8736703 0.83 ALDH1A1 (0.54) ALDH1A1MAPT
SCHEMBL13627952 0.82 ALDH1A1 (0.41) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL18954770 0.81 CA1 (0.69)
SCHEMBL18954691 0.78 TGM2 (0.68) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL5430327 0.77 CHRM1 (0.63) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL4609842 0.77 CES1 (0.66) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL15928248 0.77 TGM2 (0.75) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL18974754 0.77 TGM2 (0.61) TGM2CES1ALDH1A1ALDH3A1CHRM1
SCHEMBL18954909 0.77 ALDH1A1 (0.71) TGM2CES1ALDH1A1ALDH3A1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 WO disclosed